A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Conditions
Kidney Transplant Rejection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Brigham & Women's Hospital- Site Number : 8400049, Boston, Massachusetts, United States
Montefiore Medical Center - Moses Campus- Site Number : 8400006, The Bronx, New York, United States
Investigational Site Number : 0320001, Corrientes, Argentina
Investigational Site Number : 0360002, Adelaide, South Australia, Australia
Investigational Site Number : 0360001, Parkville, Victoria, Australia
Investigational Site Number : 0360003, Sydney, Australia
Investigational Site Number : 0560002, Brussels, Belgium
Investigational Site Number : 1520005, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520004, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1560003, Chengdu, China
Investigational Site Number : 1560012, Jinan, China
Investigational Site Number : 1560017, Nanchang, China
Investigational Site Number : 1560008, Nanning, China
Investigational Site Number : 1560001, Shanghai, China
Investigational Site Number : 1560011, Tianjin, China
Investigational Site Number : 1560006, Wuhan, China
Investigational Site Number : 1560005, Zhengzhou, China
Investigational Site Number : 1560009, Zhengzhou, China
Investigational Site Number : 2080001, Aarhus, Denmark
Investigational Site Number : 3760002, Ramat Gan, Israel
Torette, Ancona, Italy
Investigational Site Number : 7240001, Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 7240007, Barcelona, Catalunya [Cataluña], Spain
Investigational Site Number : 7240003, L'Hospitalet de Llobregat, Catalunya [Cataluña], Spain
Investigational Site Number : 7240005, Málaga, Spain
Investigational Site Number : 8260001, Birmingham, England, United Kingdom